Phase 1 Uterine Carcinosarcoma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Ovarian CancerEndometrial CancerTriple Negative Breast Cancer(TNBC)+4 more

NiKang Therapeutics, Inc.205 enrolled14 locationsNCT07029399

Recruiting

Phase 1Phase 2

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Triple-Negative Breast CancerAdvanced Solid TumorHead and Neck Squamous Cell Carcinoma+7 more

Volastra Therapeutics, Inc.200 enrolled14 locationsNCT05902988